Lumine Na

467 total citations
12 papers, 312 citations indexed

About

Lumine Na is a scholar working on Oncology, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Lumine Na has authored 12 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Infectious Diseases and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Lumine Na's work include HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (3 papers) and HIV/AIDS Research and Interventions (2 papers). Lumine Na is often cited by papers focused on HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (3 papers) and HIV/AIDS Research and Interventions (2 papers). Lumine Na collaborates with scholars based in Australia, United States and United Kingdom. Lumine Na's co-authors include Joseph J. Eron, Katie R. Mollan, Thomas Campbell, Kevin R. Robertson, Paul E. Sax, Roy M. Gulick, Marlene Smurzynski, Camlin Tierney, Eric S. Daar and Vedat Deviren and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and JNCI Journal of the National Cancer Institute.

In The Last Decade

Lumine Na

12 papers receiving 307 citations

Peers

Countries citing papers authored by Lumine Na

Since Specialization

Citations

This map shows the geographic impact of Lumine Na's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lumine Na with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lumine Na more than expected).

Fields of papers citing papers by Lumine Na

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lumine Na. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lumine Na. The network helps show where Lumine Na may publish in the future.

Co-authorship network of co-authors of Lumine Na

This figure shows the co-authorship network connecting the top 25 collaborators of Lumine Na. A scholar is included among the top collaborators of Lumine Na based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lumine Na. Lumine Na is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	A randomised controlled trial of clinical pharmacy intervention versus standard care to improve medication adherence in outpatients with head and neck cancer receiving radiotherapy 2022 ·Supportive Care in Cancer ·(unknown), (unknown), Tsien Fua, Chen Liu, Danny Rischin, Marliese Alexander, Lumine Na, Senthil Lingaratnam	6
2	Assessment of Ovarian Function in Phase III (Neo)Adjuvant Breast Cancer Clinical Trials: A Systematic Evaluation 2021 ·JNCI Journal of the National Cancer Institute ·Wanyuan Cui, Prudence A. Francis, Sherene Loi, Martha Hickey, Catharyn Stern, Lumine Na, Ann H. Partridge, Sibylle Loibl, Richard A. Anderson, Karla J. Hutt, Louise Keogh, Kelly‐Anne Phillips	17
3	Efficacy of immune checkpoint inhibitors for in-transit melanoma 2020 ·Journal for ImmunoTherapy of Cancer ·(unknown), Julia Lai‐Kwon, (unknown), Lumine Na, (unknown), (unknown), Victoria Atkinson, George Au‐Yeung, Georgina V. Long, Grant A. McArthur, Shahneen Sandhu, Robyn P.M. Saw, Euan Walpole, Alexander M. Menzies, B. Mark Smithers, David Gyorki	21
4	Correlation between percutaneous biopsy and final histopathology for retroperitoneal sarcoma: a single‐centre study 2020 ·ANZ Journal of Surgery ·(unknown), Hayden Snow, Shona Hendry, Catherine Mitchell, John Slavin, Stephen Schlicht, Lumine Na, Michael S. Hofman, David Gyorki	13
5	Association Between Efavirenz as Initial Therapy for HIV-1 Infection and Increased Risk for Suicidal Ideation or Attempted or Completed Suicide: An Analysis of Trial Data 2020 ·UNC Libraries ·Lumine Na, (unknown), Joseph J. Eron, Paul E. Sax, Eric S. Daar, Marlene Smurzynski, Kevin R. Robertson, Roy M. Gulick, Camlin Tierney, Katie R. Mollan, Thomas Campbell	7
6	Negative Sentinel Lymph Node Biopsy in Patients with Melanoma: The Patient’s Perspective 2019 ·Annals of Surgical Oncology ·(unknown), Donna Milne, (unknown), Lumine Na, John Spillane, David Speakman, Michael A. Henderson, David Gyorki	6
7	Efficacy of immune checkpoint inhibitors (ICIs) for in-transit melanoma. 2019 ·Journal of Clinical Oncology ·(unknown), (unknown), Lumine Na, (unknown), (unknown), (unknown), Victoria Atkinson, George Au‐Yeung, Georgina V. Long, Grant A. McArthur, Shahneen Sandhu, Robyn P.M. Saw, Euan Walpole, Alexander M. Menzies, B. Mark Smithers, David Gyorki	1
8	Unreported Summary Statistics in Trial Publications and Risk of Bias in Stroke Rehabilitation Systematic Reviews: An International Survey of Review Authors and Examination of Practical Solutions 2019 ·Edinburgh Research Explorer ·Christopher J. Weir, Valentina Assi, Lumine Na, Steff Lewis, Gordon Murray, Peter Langhorne, Marian Brady	3
9	The RAPID-CTCA trial (Rapid Assessment of Potential Ischaemic Heart Disease with CTCA) — a multicentre parallel-group randomised trial to compare early computerised tomography coronary angiography versus standard care in patients presenting with suspected or confirmed acute coronary syndrome: study protocol for a randomised controlled trial 2016 ·Trials ·Alasdair Gray, Carl Roobottom, Jason Smith, Steve Goodacre, Katherine Oatey, Rachel O’Brien, Robert F. Storey, Lumine Na, Steff Lewis, Praveen Thokala, David E. Newby	24
10	Regimen selection in the OPTIONS trial of HIV salvage therapy: drug resistance, prior therapy, and race–ethnicity determine the degree of regimen complexity 2015 ·HIV Clinical Trials ·Karen T. Tashima, Katie R. Mollan, Lumine Na, Rajesh T. Gandhi, Karin L. Klingman, Carl J. Fichtenbaum, Adriana Andrade, Victoria A. Johnson, Joseph J. Eron, Laura Smeaton, Richard Haubrich	9
11	Association Between Efavirenz as Initial Therapy for HIV-1 Infection and Increased Risk for Suicidal Ideation or Attempted or Completed Suicide 2014 ·Annals of Internal Medicine ·Katie R. Mollan, Marlene Smurzynski, Joseph J. Eron, Eric S. Daar, Thomas Campbell, Paul E. Sax, Roy M. Gulick, Lumine Na, (unknown), Kevin R. Robertson, Camlin Tierney	151
12	Pitfalls of calculating hospital readmission rates based on nonvalidated administrative data sets 2012 ·Journal of Neurosurgery Spine ·(unknown), Tsung-Hsi Tu, William W. Schairer, Lumine Na, Steven K. Takemoto, Sigurd Berven, Vedat Deviren, Christopher P. Ames, Dean Chou, Praveen V. Mummaneni	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact